Table 2.

 Distribution of cases between ‘low’ (0–1) and ‘high’ scores (2–3) of SMF by age, margin status, risk score, disease recurrence, and dead of disease state

SMF	Age		Margin status†		Risk score		Recurrence (%)	Dead of disease (%)
	‘Young’≤60 years (%)	‘Old’ >60 years (%)	‘Clean’ (%)	Positive (%)	Low‐to‐intermediate (0–2) (%)	High (≥3) (%)
Low (0–1) (n = 23)	8 (34.8)	15 (65.2)	16 (69.6)	6 (26.1)	10 (43.5)	13 (56.5)	3 (13)	2 (8.7)
High (2–3) (n = 27)	15 (55.5)	12 (44.5)	16 (59.3)	11 (40.7)	2 (7.4)	25 (92.6)	14 (51.8)	11 (40.7)

†n = 49. SMF, stromal myofibroblasts.